InvestorsHub Logo

jour_trader

01/25/24 4:05 PM

#394464 RE: imanjen13 #394463

How could it be flat when you include Prasco launch quantity?

Mophron

01/25/24 5:30 PM

#394475 RE: imanjen13 #394463

Nasrat did say a few calls ago that it would the third quarter of selling under Kirkov that would show the most growth.

The ELTP King

01/26/24 3:22 AM

#394496 RE: imanjen13 #394463

Looks like someone didn't read the last two FDA/DEA letters about quota....

While Adderall is currently a very hot drug which has high demand, the amount of product a company can sell is limited by the API available and the DEA quota.

The ELTP King

01/26/24 3:24 AM

#394497 RE: imanjen13 #394463

I'm actually expecting MORE than $20 million.

Revenue guessing game begins February 5.

The expectation of a $20 million quarter is troubling

alstutil

01/26/24 7:44 AM

#394503 RE: imanjen13 #394463

For the last 5 out of 6 quarters - sales rev $ exceeded the prior quarter ending inventory balance - we ended with $15m in inventory last qtr - inventory is recorded at the lower of cost or market. My conservative guess is $18.6M in revenue.

Qtr ending sept 2023 $14.1M Rev vs prior qtr inventory $11.16M